Madison Square Garden Sports (MSGS) Earnings Analysis
Madison Square Garden Sports (MSGS) has no confirmed upcoming earnings date. Last quarter (2026-05-08) it missed with EPS -0.78 USD vs 0.56 USD est (-239.3%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -425.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MSGS next report earnings?
No confirmed upcoming earnings date is currently scheduled for MSGS. This page updates as the calendar is published.
MSGS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -0.78 USD | 0.56 USD | -239.3% | Miss |
| 2026-02-05 | 0.34 USD | 0.66 USD | -48.5% | Miss |
| 2025-10-31 | -0.37 USD | -1.04 USD | +64.4% | Beat |
| 2025-08-12 | -0.07 USD | -0.42 USD | +83.3% | Beat |
| 2025-05-02 | -0.59 USD | 1.48 USD | -139.9% | Miss |
| 2024-11-01 | -0.31 USD | -0.88 USD | +64.8% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
MSGS valuation and analyst view
| Trailing P/E | -425.41 |
|---|---|
| Trailing EPS | -0.92418 USD |
| Price / book | -32.47 |
| Dividend yield | 0.00% |
| Market cap | 9.61B |
| Analyst consensus | Buy (20 buy / 9 hold / 0 sell) |
| Avg price target | 448.78 USD |
Related research pages
Frequently asked questions
When is Madison Square Garden Sports (MSGS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for MSGS. This page updates as the calendar is published.
Did MSGS beat earnings last quarter?
In its 2026-05-08 report, MSGS posted EPS of -0.78 USD versus a 0.56 USD estimate — a miss of 239.3%.
What is MSGS's earnings track record?
Over the last 6 reported quarters with consensus data, MSGS beat estimates 3 times (50%).
What is MSGS's current P/E ratio and EPS?
MSGS trades at a trailing P/E of -425.41 on trailing EPS of -0.9241790550333348 USD.
What do analysts rate MSGS?
Analyst consensus is "Buy" across 29 ratings (0 strong buy, 20 buy, 9 hold, 0 sell, 0 strong sell). Average 12-month price target: 448.78 USD.